Neodynamics

0,449SEK -1,21 %

HC Andersen Capital modtager betaling fra Neodynamics for en Digital IR/Corporate Visibility abonnementsaftale. Læs mere her.

6 investorer følger denne virksomhed

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

Omsætning
140 t
EBIT %
-52.307,14 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NEOD
Daglig lav / høj pris
0,42 / 0,48 SEK
Markedsværdi
54,11 mio. SEK
Aktieomsætning
224,94 t SEK
Volumen
503 t

Forum opdateringer

Hold dig opdateret med den seneste information fra Neodynamics
Publisher
NeoDynamics - Presentation of Q1 interim report 2023

Meet CFO Aaron Wong who will give an update on the Q1 results and further dive into the development for NeoNavia in Europe. The event takes place Friday the 12th of May at 10.00 AM.

Videopræsentation12.05.2023
Publisher
Fast comment - NeoDynamics present at The SBI Breast Imaging Symposium

NeoDynamics present final data set from the PULSE Study at The SBI Breast Imaging Symposium....

Analytikerkommentar05.05.2023 af Claus Thestrup
Publisher
NeoDynamics publishes Annual Report 2022

NeoDynamics has published their annual report for the financial year 2022.

Analytikerkommentar03.05.2023 af Claus Thestrup
Publisher
Notice of Annual General Meeting in NeoDynamics

The shareholders in NeoDynamics have been conveyed to the annual general meeting on Tuesday 23 May 2023 at 15.00 at the Company’s premises at Lejonvägen 14, Lidingö.

Analytikerkommentar25.04.2023 af Claus Thestrup
Publisher
Dagens aktienyheder 04/04

MapsPeople har i en pressemeddelelse annonceret en udvidelse af selskabets kortlægningsmuligheder. NeoDynamics gave yesterday an update on delivery of needles in Europe and US. NeoDynamics : The Extraordinary General Meeting. Qlife: The nomination committee’s proposal for new board members.

Analytikerkommentar04.04.2023
Publisher
Dagens aktienyheder 17/03

BioPorto A/S’s aktier faldt knap 11 procent i går efter at selskabet udsendte en update. Odico A/S har modtaget en ny ordre inden for forretningsområdet Digital Fabrikation. Ascelia Pharma AB afholdt tidligere på ugen et kapitalmarkedsevent. One-pager på Shape Robotics. NeoDynamics : Interview with CEO Anna Eriksrud and Aaron Wong FCCA

Analytikerkommentar17.03.2023
Publisher
NeoDynamics: Management elaborates on options for long-term financing

We hosted an event Wednesday the 15th of March with CEO Anna Eriksrud and CFO Aaron Wong on funding as is and to be.

Analytikerkommentar16.03.2023 af Claus Thestrup
Publisher
NeoDynamics – Management elaborates on options for long-term financing

Meet CEO Anna Eriksrud and CFO Aaron Wong who will elaborate on options to raise long-term capital to enable the commercialization of NeoNavia in the US. The event takes place Wednesday the 15th. of March 2.00 PM.

Videopræsentation15.03.2023
Publisher
Dagens aktienyheder 07/03

Skjern Bank handler i dag ex. udbytte på DKK 3 pr. aktie. NeoDynamics meddelte i går, at man nu også har fået patent på sit FlexiPulse produkt i Kina. Pharma Equity Group A/S er nyt dansk biotek selskab.

Analytikerkommentar07.03.2023
Publisher
Dagens aktienyheder 01/03

Green Hydrogen Systems er her til morgen ude med årsrapporten for 2022. Re-Match melder her til morgen, at de har til hensigt at lade sig afnotere. Bavarian Nordic, der i 2022 påbegyndte et fase 3 studie af sin RSV-vaccine kandidat, og forventer foreløbige resultater i midten af 2023. Event med Hafnia. NeoDynamics investigate options to raise longterm financing.

Analytikerkommentar01.03.2023